CVS HEALTH CORPORATION Policyholder Account Balance, Interest Expense
CVS HEALTH CORPORATION (CVS) reported Policyholder Account Balance, Interest Expense of $8.00 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InterestCreditedToPolicyholdersAccountBalances · last filed 2024-11-06
- CVS HEALTH CORPORATION policyholder account balance, interest expense for the quarter ending 2024-09-30 was $2.00M, a 50.00% decline year-over-year.
- CVS HEALTH CORPORATION policyholder account balance, interest expense for the quarter ending 2024-06-30 was $3.00M, a 50.00% increase year-over-year.
- CVS HEALTH CORPORATION policyholder account balance, interest expense for the quarter ending 2024-03-31 was $3.00M, a 0.00% change year-over-year.
- CVS HEALTH CORPORATION policyholder account balance, interest expense for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- CVS HEALTH CORPORATION policyholder account balance, interest expense for fiscal 2023 was $9.00M, a 18.18% decline from fiscal 2022.
- CVS HEALTH CORPORATION policyholder account balance, interest expense for fiscal 2022 was $11.00M.
| Period end | Policyholder Account Balance, Interest Expense 3 month | Policyholder Account Balance, Interest Expense 6 month | Policyholder Account Balance, Interest Expense 9 month | Policyholder Account Balance, Interest Expense 12 month |
|---|---|---|---|---|
| 2024-09-30 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $5.00M derived: sum of 2 quarters · filed 2024-11-06 | $8.00M 10-Q · filed 2024-11-06 | $8.00M derived: sum of 4 quarters · filed 2024-11-06 |
| 2024-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $6.00M 10-Q · filed 2024-08-07 | $6.00M derived: sum of 3 quarters · filed 2024-08-07 | $10.00M derived: sum of 4 quarters · filed 2024-11-06 |
| 2024-03-31 | $3.00M 10-Q · filed 2024-05-01 | $3.00M derived: sum of 2 quarters · filed 2024-05-01 | $7.00M derived: sum of 3 quarters · filed 2024-11-06 | $9.00M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | $4.00M derived: sum of 2 quarters · filed 2024-11-06 | $6.00M derived: sum of 3 quarters · filed 2024-11-06 | $9.00M 10-K · filed 2024-02-07 |
| 2023-09-30 | $4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $6.00M derived: sum of 2 quarters · filed 2024-11-06 | $9.00M 10-Q · filed 2024-11-06 | $10.00M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $5.00M 10-Q · filed 2024-08-07 | $6.00M derived: sum of 3 quarters · filed 2024-08-07 | $9.00M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $3.00M 10-Q · filed 2024-05-01 | $4.00M derived: sum of 2 quarters · filed 2024-05-01 | $7.00M derived: sum of 3 quarters · filed 2024-05-01 | $10.00M derived: sum of 4 quarters · filed 2024-05-01 |
| 2022-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | $4.00M derived: sum of 2 quarters · filed 2024-02-07 | $7.00M derived: sum of 3 quarters · filed 2024-02-07 | $11.00M 10-K · filed 2024-02-07 |
| 2022-09-30 | $3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $6.00M derived: sum of 2 quarters · filed 2023-11-01 | $10.00M 10-Q · filed 2023-11-01 | |
| 2022-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $7.00M 10-Q · filed 2023-08-02 | ||
| 2022-03-31 | $4.00M 10-Q · filed 2023-05-03 | |||
| 2021-12-31 | $12.00M 8-K · filed 2023-05-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |